Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys. - Wikidata - wikimedia - TriplyDB

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

http://www.wikidata.org/entity/Q36300153

about

HIV-Host Interactions: Implications for Vaccine Design Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions Immune correlates of vaccine protection against HIV-1 acquisition Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 Elimination of HIV-1-infected cells by broadly neutralizing antibodies New concepts in HIV-1 vaccine development VirusSeeker, a computational pipeline for virus discovery and virome composition analysis Systems serology for evaluation of HIV vaccine trials.Survivors Remorse: antibody-mediated protection against HIV-1.Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Current views on the potential for development of a HIV vaccine.Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys.Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.Statoviruses, A novel taxon of RNA viruses present in the gastrointestinal tracts of diverse mammals Hyperexpansion of RNA Bacteriophage Diversity.Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control.SIV Infection-Mediated Changes in Gastrointestinal Bacterial Microbiome and Virome Are Associated with Immunodeficiency and Prevented by Vaccination Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.Epitope Mapping of a Monoclonal Antibody Directed against Neisserial Heparin Binding Antigen Using Next Generation Sequencing of Antigen-Specific Libraries Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization.Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001 TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses.Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus.Natural infection as a blueprint for rational HIV vaccine design.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Immunogenicity of a Multi-Epitope DNA Vaccine Encoding Epitopes from Cu-Zn Superoxide Dismutase and Open Reading Frames of Brucella abortus in Mice.Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection.HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques.Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination.Engineering broadly neutralizing antibodies for HIV prevention and therapy.

P2860

Q26765966-5CE626DD-2AE7-42A9-9746-8546FD2093A1 Q26777442-856E8202-8E29-4DA4-9572-7BB18F22DCA8 Q26778573-DF0BAF7C-B1F8-43CA-AF49-262D38CEC4BA Q26782237-E1CD24E8-1FCA-4BDE-B4AA-36863433CCBF Q27329126-3AA0EA3D-B9EE-42E4-B245-9F38664E7BD9 Q28067027-CE97C031-825C-4196-B009-A5B3BB496E07 Q28581579-8F6CCCF7-B158-4676-8371-94DD8B260970 Q30238729-46FE7518-F02E-425F-825A-B483ACA95592 Q30238730-6CB84C97-D504-466D-A165-887D9C3FEA79 Q30390233-9C5E5C6B-921F-40DB-ACE0-4CEE24C3A0D7 Q30397595-145705E8-50F4-4043-BE7B-B6AD7B61C5BD Q33603602-B3D94B73-5849-4BB9-B3F3-48A9CD4D0430 Q33780980-E12F1BEE-145D-431E-8A07-ACF3A60F82C8 Q33804531-AF0A10E9-362B-4DB1-8204-DA602EBC5E53 Q33851717-61BE35AE-1FC0-49F3-A69F-A1D6D04550DD Q33914867-93A38165-1052-4D0C-AFDA-CADD135E477B Q34519652-FF7D15C7-1CA3-420B-A6E8-846AF17C0F8E Q34540352-09AC549A-5241-46DC-B97E-F0C85A8F15CC Q35888710-A50F7573-CF05-4F49-9A40-6B98342B5F3A Q35952139-BF49A7FD-91C4-4534-9DF4-B57406A77B38 Q35985519-CA922E92-B782-4A29-A64B-5AFDB1A1B53A Q36100035-23024A38-6C2B-4AB9-8049-AF0396D4D1D1 Q36118373-9C316147-9351-4414-901F-DDACB4900013 Q36481537-0A53FBC2-CF72-4468-8FC7-7B95B4BB7F23 Q36708266-3F189FC7-C399-4C2B-A7F7-C28E3208ACF8 Q37287424-AE9F65AD-280A-4763-8470-42E6ED35B265 Q37409262-24FB1072-B48D-40D9-ADD9-9E13839F1C34 Q37448315-09F153DE-3C0B-4A0E-8437-0D0CE23CE956 Q37497214-6E349BDC-0708-4C98-90D4-5DAFF71892A5 Q37510242-D8142F71-C21A-4DEF-84C2-A4CAC373DBA2 Q37586965-39278957-9870-452E-BB55-12C720094037 Q37619134-DFDE380B-6CA4-4600-B8E7-B2C59CD56890 Q37621530-7079333C-EAAD-4526-BC35-6A942F14553B Q37632905-5CAC8AD3-F52D-4D2D-B9D1-6FA688350A47 Q37677278-FB9CD30A-90FD-47D6-8625-BA0090BF7289 Q37727880-96A813C6-2C1D-4486-93EB-35E49FDE0394 Q38631751-9E7009C3-2307-41FB-949F-16EC6F522CD3 Q38652858-2B795BDE-60B2-49D3-B5C9-CF70407A5025 Q38702368-D058EE1F-4749-4E05-A487-AA8AC86E24FF Q38717198-FC8BDBF8-7120-450B-B611-F0A28D66A527

P2860

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

http://www.wikidata.org/entity/Q36300153

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@ast

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@en

type

label

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@ast

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@en

prefLabel

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@ast

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@en

P1433

Q36300153-0A862366-F6FD-454F-9E0E-DB630BF96FAC

P1476

Q36300153-8774538C-C02B-42D8-98FD-6AC1E63B039F

P2093

Q36300153-0C9AF387-3DA9-45A6-84D4-2773ACD8233D

Q36300153-11F33B4C-FA64-41E2-B72D-56D5B0FD8DA9

Q36300153-14F94640-4977-4352-B9C1-AE0DA83E34BF

Q36300153-247D1B09-3D9A-46A6-81E7-734971F7F410

Q36300153-26C012A7-8B58-44AD-9BE6-3CA856D0101A

Q36300153-42BE1B2D-24EC-4486-A2A7-833313C4ACA3

Q36300153-4F7F7F97-44D2-491A-883C-CB68B18528F7

Q36300153-567CFF9D-443A-4A5F-B88D-BC6A6AE62DCB

Q36300153-5B176F24-0A3C-4EEA-B5B2-042605005668

Q36300153-6D836962-A3E1-4845-9BBE-E75752B3841B

P2860

Q36300153-096A7C43-B19C-4DAD-8A81-319810842E96

Q36300153-20FDBC2E-75B6-4C78-BF6E-D2C23B9AA874

Q36300153-27530072-771D-40CC-B95E-9522559456BC

Q36300153-27D9116A-15DE-4663-82A8-C4CE3F3BA6EA

Q36300153-324D4A86-6CAA-4B2C-AB50-C2AA11E8C55F

Q36300153-338C9DF5-00CF-4D5A-9F49-D4D5AEF2C1F6

Q36300153-393AB118-A6AE-4BD5-87E5-F015E9E38738

Q36300153-3C012338-BE4A-474C-8E14-4D35D7A77D2B

Q36300153-3E627692-4172-4182-8A07-2E6B68E2EC2D

Q36300153-3E795AF0-4ED1-48AE-A671-AEA78D560D16

P304

Q36300153-26072FCC-E13F-4971-A7AD-04B467BD799A

P31

Q36300153-CF4806C4-DD79-4BEB-899D-B5222138D487

P356

Q36300153-AC3074C6-7351-4578-A645-619FE9F3AB4A

P407

Q36300153-30534E07-8E69-4E6F-A1E3-F8FF6298B6CC

P433

Q36300153-A74029DE-55BE-43D8-9493-98544AC2A587

P478

Q36300153-909204A3-A765-4D65-AA2A-8F92EE4BCEBB

P50

Q36300153-059EC1C9-61B6-47EA-81FB-829137286A76

Q36300153-07B3852A-A466-4D5A-8CD5-8D38AB7287D9

Q36300153-469C77A6-735F-4A61-8212-0A23923613CC

Q36300153-53E9A0A0-A06F-4FBF-A9ED-C60F4AC02F78

Q36300153-E607064C-CA5D-40BD-8DD6-92B9BFAB57C9

Q36300153-F707F5C8-4EBA-4EF6-89DC-20A853CFEDDA

P577

Q36300153-8046098C-C53A-44C9-A1F6-C1E356617237

P5875

Q36300153-1FA06145-53F1-4FAB-9778-6320E14A3152

P698

Q36300153-76BA6ECA-4286-4D66-A5EC-5FD6188C750C

P921

Q36300153-6A35E4CB-3D80-4DC6-933A-8CA2C8DCA500

P932

Q36300153-24DDA6A6-74C6-4A3C-8920-2ADC8301E722

P356

SCIENCE.AAB3886

P1433

P1476

Protective efficacy of adenovi ...... challenges in rhesus monkeys.

@en

P2093

Arnaud D Colantonio

http://www.w3.org/2001/XMLSchema#string

Bing Chen

http://www.w3.org/2001/XMLSchema#string

Caitlyn Linde

http://www.w3.org/2001/XMLSchema#string

Christy L Lavine

http://www.w3.org/2001/XMLSchema#string

Clarisse Lorin

http://www.w3.org/2001/XMLSchema#string

David M Ng'ang'a

http://www.w3.org/2001/XMLSchema#string

Erica N Borducchi

http://www.w3.org/2001/XMLSchema#string

Galit Alter

http://www.w3.org/2001/XMLSchema#string

Gerald Voss

http://www.w3.org/2001/XMLSchema#string

Hanneke Schuitemaker

http://www.w3.org/2001/XMLSchema#string

P2860

IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates

Integrative analysis of environmental sequences using MEGAN4

High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

CD-HIT: accelerated for clustering the next-generation sequencing data

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs

P304

320-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAB3886

http://www.w3.org/2001/XMLSchema#string

P407

P433

6245

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

Herbert W. "Skip" Virgin

P577

2015-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279728298

http://www.w3.org/2001/XMLSchema#string

P698

26138104

http://www.w3.org/2001/XMLSchema#string

P921

P932

4653134

http://www.w3.org/2001/XMLSchema#string